595 related articles for article (PubMed ID: 27034112)
1. Perivascular delivery of resolvin D1 inhibits neointimal hyperplasia in a rat model of arterial injury.
Wu B; Mottola G; Chatterjee A; Lance KD; Chen M; Siguenza IO; Desai TA; Conte MS
J Vasc Surg; 2017 Jan; 65(1):207-217.e3. PubMed ID: 27034112
[TBL] [Abstract][Full Text] [Related]
2. Perivascular delivery of resolvin D1 inhibits neointimal hyperplasia in a rabbit vein graft model.
Wu B; Werlin EC; Chen M; Mottola G; Chatterjee A; Lance KD; Bernards DA; Sansbury BE; Spite M; Desai TA; Conte MS
J Vasc Surg; 2018 Dec; 68(6S):188S-200S.e4. PubMed ID: 30064835
[TBL] [Abstract][Full Text] [Related]
3. Proresolving Lipid Mediators Resolvin D1 and Protectin D1 Isomer Attenuate Neointimal Hyperplasia in the Rat Carotid Artery Balloon Injury Model.
Makino Y; Miyahara T; Nitta J; Miyahara K; Seo A; Kimura M; Suhara M; Akai A; Akagi D; Yamamoto K; Hoshina K
J Surg Res; 2019 Jan; 233():104-110. PubMed ID: 30502235
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of neointimal hyperplasia in the rat carotid artery injury model by a HMGB1 inhibitor.
Chen J; Zhang J; Xu L; Xu C; Chen S; Yang J; Jiang H
Atherosclerosis; 2012 Oct; 224(2):332-9. PubMed ID: 22857898
[TBL] [Abstract][Full Text] [Related]
5. 17R/S-Benzo-RvD1, a synthetic resolvin D1 analogue, attenuates neointimal hyperplasia in a rat model of acute vascular injury.
Kim AS; Werlin EC; Kagaya H; Chen M; Wu B; Mottola G; Jan M; Conte MS
PLoS One; 2022; 17(2):e0264217. PubMed ID: 35226675
[TBL] [Abstract][Full Text] [Related]
6. Unidirectional and sustained delivery of the proresolving lipid mediator resolvin D1 from a biodegradable thin film device.
Lance KD; Chatterjee A; Wu B; Mottola G; Nuhn H; Lee PP; Sansbury BE; Spite M; Desai TA; Conte MS
J Biomed Mater Res A; 2017 Jan; 105(1):31-41. PubMed ID: 27508346
[TBL] [Abstract][Full Text] [Related]
7. Rapamycin-loaded nanoparticles for inhibition of neointimal hyperplasia in experimental vein grafts.
Zou J; Zhang X; Yang H; Zhu Y; Ma H; Wang S
Ann Vasc Surg; 2011 May; 25(4):538-46. PubMed ID: 21549923
[TBL] [Abstract][Full Text] [Related]
8. Systemic delivery of proresolving lipid mediators resolvin D2 and maresin 1 attenuates intimal hyperplasia in mice.
Akagi D; Chen M; Toy R; Chatterjee A; Conte MS
FASEB J; 2015 Jun; 29(6):2504-13. PubMed ID: 25777995
[TBL] [Abstract][Full Text] [Related]
9. Sodium ferulate inhibits neointimal hyperplasia in rat balloon injury model.
Zhang J; Chen J; Yang J; Xu C; Ding J; Yang J; Guo Q; Hu Q; Jiang H
PLoS One; 2014; 9(1):e87561. PubMed ID: 24489938
[TBL] [Abstract][Full Text] [Related]
10. MFAP4 Promotes Vascular Smooth Muscle Migration, Proliferation and Accelerates Neointima Formation.
Schlosser A; Pilecki B; Hemstra LE; Kejling K; Kristmannsdottir GB; Wulf-Johansson H; Moeller JB; Füchtbauer EM; Nielsen O; Kirketerp-Møller K; Dubey LK; Hansen PB; Stubbe J; Wrede C; Hegermann J; Ochs M; Rathkolb B; Schrewe A; Bekeredjian R; Wolf E; Gailus-Durner V; Fuchs H; Hrabě de Angelis M; Lindholt JS; Holmskov U; Sorensen GL
Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):122-33. PubMed ID: 26564819
[TBL] [Abstract][Full Text] [Related]
11. D-series resolvin attenuates vascular smooth muscle cell activation and neointimal hyperplasia following vascular injury.
Miyahara T; Runge S; Chatterjee A; Chen M; Mottola G; Fitzgerald JM; Serhan CN; Conte MS
FASEB J; 2013 Jun; 27(6):2220-32. PubMed ID: 23407709
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide and nanotechnology: a novel approach to inhibit neointimal hyperplasia.
Kapadia MR; Chow LW; Tsihlis ND; Ahanchi SS; Eng JW; Murar J; Martinez J; Popowich DA; Jiang Q; Hrabie JA; Saavedra JE; Keefer LK; Hulvat JF; Stupp SI; Kibbe MR
J Vasc Surg; 2008 Jan; 47(1):173-82. PubMed ID: 18178471
[TBL] [Abstract][Full Text] [Related]
13. Gliotoxin inhibits neointimal hyperplasia after vascular injury in rats.
Pozo M; Izquierdo MC; de Nicolás R; Egido J; Ortiz A; González-Cabrero J
J Vasc Res; 2009; 46(4):278-89. PubMed ID: 19033690
[TBL] [Abstract][Full Text] [Related]
14. Intraluminal Delivery of Simvastatin Attenuates Intimal Hyperplasia After Arterial Injury.
Helkin A; Bruch D; Wilson DR; Gruessner AC; Bader RR; Maier KG; Gahtan V
Vasc Endovascular Surg; 2019 Jul; 53(5):379-386. PubMed ID: 30982448
[TBL] [Abstract][Full Text] [Related]
15. BubR1 insufficiency inhibits neointimal hyperplasia through impaired vascular smooth muscle cell proliferation in mice.
Kyuragi R; Matsumoto T; Harada Y; Saito S; Onimaru M; Nakatsu Y; Tsuzuki T; Nomura M; Yonemitsu Y; Maehara Y
Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):341-7. PubMed ID: 25524773
[TBL] [Abstract][Full Text] [Related]
16. Naringenin inhibits angiotensin II-induced vascular smooth muscle cells proliferation and migration and decreases neointimal hyperplasia in balloon injured rat carotid arteries through suppressing oxidative stress.
Xu C; Chen J; Zhang J; Hu X; Zhou X; Lu Z; Jiang H
Biol Pharm Bull; 2013; 36(10):1549-55. PubMed ID: 23912743
[TBL] [Abstract][Full Text] [Related]
17. Nobiletin Inhibits PDGF-BB-induced vascular smooth muscle cell proliferation and migration and attenuates neointimal hyperplasia in a rat carotid artery injury model.
Guan S; Tang Q; Liu W; Zhu R; Li B
Drug Dev Res; 2014 Dec; 75(8):489-96. PubMed ID: 25452110
[TBL] [Abstract][Full Text] [Related]
18. Ginsenoside Rb₁ inhibits the carotid neointimal hyperplasia induced by balloon injury in rats via suppressing the phenotype modulation of vascular smooth muscle cells.
Zhang S; Deng J; Gao Y; Yang DL; Gong QH; Huang XN
Eur J Pharmacol; 2012 Jun; 685(1-3):126-32. PubMed ID: 22546228
[TBL] [Abstract][Full Text] [Related]
19. 3,3'Diindolylmethane suppresses vascular smooth muscle cell phenotypic modulation and inhibits neointima formation after carotid injury.
Guan H; Zhu L; Fu M; Yang D; Tian S; Guo Y; Cui C; Wang L; Jiang H
PLoS One; 2012; 7(4):e34957. PubMed ID: 22506059
[TBL] [Abstract][Full Text] [Related]
20. Oral Resolvin D1 attenuates early inflammation but not intimal hyperplasia in a rat carotid angioplasty model.
Mottola G; Werlin EC; Wu B; Chen M; Chatterjee A; Schaller MS; Conte MS
Prostaglandins Other Lipid Mediat; 2020 Feb; 146():106401. PubMed ID: 31841663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
